PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 10 |
| 2006 | 11 |
| 2007 | 17 |
| 2008 | 130 |
| 2009 | 218 |
| 2010 | 248 |
| 2011 | 275 |
| 2012 | 290 |
| 2013 | 301 |
| 2014 | 274 |
| 2015 | 287 |
| 2016 | 217 |
| 2017 | 206 |
| 2018 | 191 |
| 2019 | 204 |
| 2020 | 143 |
| 2021 | 165 |
| 2022 | 119 |
| 2023 | 187 |
| 2024 | 163 |
| 2025 | 220 |
| 2026 | 136 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Mol Cell Proteomics"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Autoantibody Reactome Profiling Reveals Distinct Humoral Immune Signatures Induced by Simulated Microgravity, Radiation, and Combined Exposure in Mice.
- Wu L, Zheng K, Yu B, Gao B, Xiao P, Wang S, Li Y, Liu R, Zhang X, Li M, Cui CP, Tian W, Yu X.
- Mol Cell Proteomics. 2026 Sep 18;25(11):101665. doi: 10.1016/j.mcpro.2026.101665. Online ahead of print.
- PMCID: PMC13691153
Wu L, et al.Mol Cell Proteomics. 2026.PMCID: PMC13691153 -
Urinary Proteomics Enables Noninvasive and Longitudinal Monitoring of Tumor Burden Dynamics and Early Recurrence in Hepatocellular Carcinoma.
- Xing X, Hu E, Song L, Zheng Z, Cai L, Ouyang J, Li J, Pan X, Liu M, Wang Y, Liu X.
- Mol Cell Proteomics. 2026 Aug 10;25(9):101635. doi: 10.1016/j.mcpro.2026.101635.
- PMCID: PMC13644515
Xing X, et al.Mol Cell Proteomics. 2026.PMCID: PMC13644515 -
An Integrated Cardiac Microtissue Proteome Map Extends Therapeutic Remodeling by Nanovesicles.
- Lozano J, Lees JG, Cross J, Aghajanzadeh T, Fang H, Kong AM, Phang RJ, Pébay A, Rai A, Lim SY, Greening DW.
- Mol Cell Proteomics. 2026 Aug 20;25(9):101643. doi: 10.1016/j.mcpro.2026.101643.
- PMCID: PMC13602716
Lozano J, et al.Mol Cell Proteomics. 2026.PMCID: PMC13602716 -
Top-Down Sequencing of Intact Proteoforms Using the timsOmni Mass Spectrometer: Accurate Determination of Co-Occurring Histone Modifications.
- Berthias F, Bilgin N, Smyrnakis A, Le Boiteux E, Kosmopoulou M, Albers C, Suckau D, Mecinović J, Papanastasiou D, Jensen ON.
- Mol Cell Proteomics. 2026 Aug 17;25(9):101640. doi: 10.1016/j.mcpro.2026.101640.
- PMCID: PMC13595144
Berthias F, et al.Mol Cell Proteomics. 2026.PMCID: PMC13595144 -
A Scalable Low-Input Redox Proteomics Workflow Enables High-Throughput Analysis of Cysteine Oxidation in 96-Well Cell Cultures.
- Kabza AM, Chu R, Trejo J, Li X, Gaffrey MJ, Hall D, Qian WJ, Zhang T.
- Mol Cell Proteomics. 2026 Aug 17;25(9):101641. doi: 10.1016/j.mcpro.2026.101641.
- PMCID: PMC13590100
Kabza AM, et al.Mol Cell Proteomics. 2026.PMCID: PMC13590100 -
Dynamic Alterations of Site-Specific N-Glycoform and Plasma Proteasome Signatures Stratify Chemotherapy Benefit in Pancreatic Ductal Adenocarcinoma.
- Gui S, Zhang Y, Xia T, Qian J, Fang Z, Ouyang W, Wang J, Chen J, Ren X, Lyu J, Cui W, Fang H.
- Mol Cell Proteomics. 2026 Aug 17;25(9):101642. doi: 10.1016/j.mcpro.2026.101642.
- PMCID: PMC13580066
Gui S, et al.Mol Cell Proteomics. 2026.PMCID: PMC13580066 -
Clone-By-Clone Therapy Guidance in Luminal Breast Cancer Via Spatial Proteomics and Patient-Derived Tumoroid.
- Lagache L, Raffo-Romero A, Duhamel M, Zirem Y, Vanseymortier M, Fournier I, Hajjaji N, Salzet M.
- Mol Cell Proteomics. 2026 Aug 12;25(9):101639. doi: 10.1016/j.mcpro.2026.101639.
- PMCID: PMC13579033
Lagache L, et al.Mol Cell Proteomics. 2026.PMCID: PMC13579033 -
MSstatsResponse: Semiparametric Statistical Model Enhances Detection of Drug-Protein Interactions in Chemoproteomics Experiments.
- Szvetecz S, Kohler D, Federspiel JD, Field SD, Jean-Beltran P, Seward RJ, Suh H, Xue L, Vitek O.
- Mol Cell Proteomics. 2026 Aug 12;25(9):101637. doi: 10.1016/j.mcpro.2026.101637.
- PMCID: PMC13580065
Szvetecz S, et al.Mol Cell Proteomics. 2026.PMCID: PMC13580065 -
N-Glycoproteomics Sample Preparation Using Commercially Available Cellulose Magnetic Particles.
- Hanzawa K, Tanaka-Okamoto M, Nemcic M, Miyamoto Y, Nakajima K.
- Mol Cell Proteomics. 2026 Aug 11;25(9):101638. doi: 10.1016/j.mcpro.2026.101638.
- PMCID: PMC13579034
Hanzawa K, et al.Mol Cell Proteomics. 2026.PMCID: PMC13579034 -
Sugar-Coded Signals: Glycan-Based Biomarkers in Rheumatoid Arthritis.
- Hires M, Hroncekova S, Dujnič V, Solovicova V, Gajdosova VP, Jane E, Lorencova L, Bertok T, Vikartovska A, Datkova A, Kasak P, Kucera R, Tkac J.
- Mol Cell Proteomics. 2026 Aug 4;25(9):101633. doi: 10.1016/j.mcpro.2026.101633.
- PMCID: PMC13571458
Hires M, et al.Mol Cell Proteomics. 2026.PMCID: PMC13571458